Adagene to Reveal Updated Data from Phase 1b/2 Study of Muzastotug in Combination with KEYTRUDA (pembrolizumab) in Colorectal Cancer  $ADAG, #Adagene, $MRK, #Merck, #MSD
#adag
#ADAG #Adagene #MRK #Merck #MSD